Literature DB >> 15809941

Prophylaxis for thromboembolic disease: recommendations from the American College of Chest Physicians--are they appropriate for orthopaedic surgery?

John J Callaghan, Lawrence D Dorr, Gerard A Engh, Arlen D Hanssen, William L Healy, Paul F Lachiewicz, Jess H Lonner, Paul A Lotke, Chitranjan S Ranawat, Merrill A Ritter, Eduardo A Salvati, Thomas P Sculco, Thomas S Thornhill.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15809941     DOI： 10.1016/j.arth.2005.01.014

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN： 0883-5403            Impact factor:   4.757


× No keyword cloud information.
  13 in total

1.  Flowtron foot-pumps for prevention of venous thromboembolism in total hip and knee replacement.

Authors:  Rocco P Pitto; Chuan K Koh
Journal:  J Orthop       Date:  2014-11-13

Review 2.  Venous thromboembolic prophylaxis for hip fractures.

Authors:  D Marsland; S C Mears; S L Kates
Journal:  Osteoporos Int       Date:  2010-11-06       Impact factor: 4.507

3.  Aspirin for elective hip and knee arthroplasty: a multimodal thromboprophylaxis protocol.

Authors:  Ettore Vulcano; Mark Gesell; Amanda Esposito; Yan Ma; Stavros G Memtsoudis; Alejandro Gonzalez Della Valle
Journal:  Int Orthop       Date:  2012-06-12       Impact factor: 3.075

4.  Does international normalized ratio level predict pulmonary embolism?

Authors:  Patricia Hansen; Benjamin Zmistowski; Camilo Restrepo; Javad Parvizi; Richard H Rothman
Journal:  Clin Orthop Relat Res       Date:  2012-02       Impact factor: 4.176

Review 5.  Rivaroxaban vs dabigatran for thromboprophylaxis after joint-replacement surgery: exploratory indirect comparison based on meta-analysis of pivotal clinical trials.

Authors:  Vladimir Trkulja; Robert Kolundzic
Journal:  Croat Med J       Date:  2010-04       Impact factor: 1.351

Review 6.  Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty.

Authors:  Nigel E Sharrock; Alejandro Gonzalez Della Valle; George Go; Stephen Lyman; Eduardo A Salvati
Journal:  Clin Orthop Relat Res       Date:  2008-02-10       Impact factor: 4.176

7.  Similar thromboprophylaxis with rivaroxaban and low molecular weight heparin but fewer hemorrhagic complications with combined intra-articular and intravenous tranexamic acid in total knee arthroplasty.

Authors:  Panayiotis K Karampinas; Panayiotis D Megaloikonomos; Kalliopi Lampropoulou-Adamidou; Eleftherios G Papadelis; Andreas F Mavrogenis; John A Vlamis; Spyros G Pneumaticos
Journal:  Eur J Orthop Surg Traumatol       Date:  2018-09-17

8.  Thromboprophylaxis for deep vein thrombosis and pulmonary embolism after total joint arthroplasty in a low incidence population.

Authors:  Kang-Il Kim; Dong-Geun Kang; Sumit S Khurana; Sang-Hak Lee; Young-Joo Cho; Dae-Kyung Bae
Journal:  Knee Surg Relat Res       Date:  2013-05-29

9.  Association between venous thromboembolism and plasma levels of both soluble fibrin and plasminogen-activator inhibitor 1 in 170 patients undergoing total hip arthroplasty.

Authors:  Yohei Yukizawa; Yutaka Inaba; Shin-ichiro Watanabe; Satoshi Yajima; Naomi Kobayashi; Takashi Ishida; Naoyuki Iwamoto; Hyonmin Choe; Tomoyuki Saito
Journal:  Acta Orthop       Date:  2012-01-17       Impact factor: 3.717

10.  Thrombosis rates using aspirin and a compression device as multimodal prophylaxis for lower limb arthroplasty in a screened population.

Authors:  Vincent V G An; Yadin D Levy; Peter M Walker; Warwick J M Bruce
Journal:  J Clin Orthop Trauma       Date:  2018-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.